The cognitive benefits of galantamine are sustained for at least 36 months: A long-term extension trialRASKIND, Murray A; PESKIND, Elaine R; TRUYEN, Luc et al.Archives of neurology (Chicago). 2004, Vol 61, Num 2, pp 252-256, issn 0003-9942, 5 p.Article

Effect of galantamine on verbal repetition in AD : A secondary analysis of the VISTA trialROCKWOOD, Kenneth; FAY, Sherri; JARRETT, Pamela et al.Neurology. 2007, Vol 68, Num 14, pp 1116-1121, issn 0028-3878, 6 p.Article

Metabolic patterns associated with the clinical response to galantamine therapy : A fludeoxyglucose F 18 positron emission tomographic studyMEGA, Michael S; DINOV, Ivo D; PORTER, Verna et al.Archives of neurology (Chicago). 2005, Vol 62, Num 5, pp 721-728, issn 0003-9942, 8 p.Article

Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChRSAMOCHOCKI, M; ZERLIN, M; JOSTOCK, R et al.Acta neurologica Scandinavica. Supplementum. 2000, Vol 102, Num 176, pp 68-73, issn 0065-1427Conference Paper

Safety and efficacy of galantamine in subjects with mild cognitive impairmentWINBLAD, B; GAUTHIER, S; SCINTO, L et al.Neurology. 2008, Vol 70, Num 22, pp 2024-2035, issn 0028-3878, 12 p., 1Article

Bullous Pemphigoid Precipitated by Galantamine HydrobromideDIAB, Mohammad; COLOE, Jacquelyn; BECHTEL, Mark A et al.Cutis (New York, NY). 2009, Vol 83, Num 3, pp 139-140, issn 0011-4162, 2 p.Article

The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6BACHUS, R; BICKEL, U; THOMSEN, T et al.Pharmacogenetics (London). 1999, Vol 9, Num 6, pp 661-668, issn 0960-314XArticle

Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity—application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive controlSEUNGHOON HAN; LEE, Jongtae; JEON, Sangil et al.European journal of clinical pharmacology. 2012, Vol 68, Num 5, pp 599-605, issn 0031-6970, 7 p.Article

Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC―MS to UPLC―MS/MSNOETZLI, Muriel; ANSERMOT, Nicolas; DOBRINAS, Maria et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 64-65, pp 16-25, issn 0731-7085, 10 p.Article

Anticholinestérasiques: troubles graves du rythme cardiaque = Cholinesterase inhibitors: severe arrhythmiasLa Revue Prescrire. 2012, Vol 32, Num 349, issn 0247-7750, p. 833Conference Paper

Gingko biloba extract EGb 761^®: clinical data in dementiaIHL, Ralf.International psychogeriatrics. 2012, Vol 24, issn 1041-6102, S35-S40, SUP1Article

Simultaneous Determination of Nine Acetylcholinesterase Inhibitors Using Micellar Electrokinetic ChromatographyNICOLAOU, Irene N; KAPNISSI-CHRISTODOULOU, Constantina P.Journal of chromatographic science. 2011, Vol 49, Num 4, pp 265-271, issn 0021-9665, 7 p.Article

Switching cholinesterase inhibitors in older adults with dementiaMASSOUD, Fadi; DESMARAIS, Julie Eve; GAUTHIER, Serge et al.International psychogeriatrics. 2011, Vol 23, Num 3, pp 372-378, issn 1041-6102, 7 p.Article

Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamineKOTESWARA RAO, V; JANARDHAN RAO, A; SUBBA REDDY, S et al.European journal of medicinal chemistry. 2010, Vol 45, Num 1, pp 203-209, issn 0223-5234, 7 p.Article

New Prospectives in the Delivery of Galantamine for Elderly Patients Using the IntelliDrug Intraoral Device: In Vivo Animal StudiesGIANNOLA, L. I; PADERNI, C; DE CARO, V et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 6, pp 653-659, issn 1381-6128, 7 p.Article

Benzofurans as Efficient Dienophiles in Normal Electron Demand [4 + 2] CycloadditionsCHOPIN, Nathalie; GERARD, Hélène; CHATAIGNER, Isabelle et al.Journal of organic chemistry. 2009, Vol 74, Num 3, pp 1237-1246, issn 0022-3263, 10 p.Article

Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's diseaseSMITH, Gwenn S; KRAMER, Elisse; YILONG MA et al.Brain. 2009, Vol 132, pp 392-401, issn 0006-8950, 10 p., 2Article

Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment: Design and Cohort Baseline Characteristics of the German Dementia Competence NetworkKORNHUBER, Johannes; SCHMIDTKE, Klaus; JAHN, Holger et al.Dementia and geriatric cognitive disorders. 2009, Vol 27, Num 5, pp 404-417, issn 1420-8008, 14 p.Article

Galantamine inhibits |3-amyloid aggregation and cytotoxicityMATHARU, Balpreet; GIBSON, Gillian; PARSONS, Richard et al.Journal of the neurological sciences. 2009, Vol 280, Num 1-2, pp 49-58, issn 0022-510X, 10 p.Article

Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive ratsKHOSROW TAYEBATI, Seyed; DI TULLIO, Maria Antonietta; TOMASSONI, Daniele et al.Journal of the neurological sciences. 2009, Vol 283, Num 1-2, pp 187-194, issn 0022-510X, 8 p.Conference Paper

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer's Disease: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled TrialARONSON, Stephen; VAN BAELEN, Bart; KAVANAGH, Shane et al.Drugs & aging. 2009, Vol 26, Num 3, pp 231-239, issn 1170-229X, 9 p.Article

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamineRODDA, Joanne; MORGAN, Shirlony; WALKER, Zuzana et al.International psychogeriatrics. 2009, Vol 21, Num 5, pp 813-824, issn 1041-6102, 12 p.Article

A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depressionHOLTZHEIMER, Paul E; MEEKS, Thomas W; BYRD, Eve H et al.International journal of geriatric psychiatry. 2008, Vol 23, Num 6, pp 625-631, issn 0885-6230, 7 p.Article

Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease : a descriptive analysis from the VISTA clinical trialCOOK, Cheryl; FAY, Sherri; ROCKWOOD, Kenneth et al.International psychogeriatrics. 2008, Vol 20, Num 5, pp 952-963, issn 1041-6102, 12 p.Article

Post-ischemic continuous administration of galantamine attenuates cognitive deficits and hippocampal neurons loss after transient global ischemia in gerbilsXUNHE JI; CHAOYUE LI; YI LU et al.Neuroscience letters. 2007, Vol 416, Num 1, pp 92-95, issn 0304-3940, 4 p.Article